Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)

Clinical trial NCT00935987 · COMPLETED

Trial details

NCT number: NCT00935987
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis

Start date: 2009-11-01
Primary completion: 2012-04-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.